Scenarios I believe we have a few scenarios to look at:
1. Aristotle will be launched any day as we have expanded the testing facilities and can do both Covid testing and Cancer testing at the same time.
2. Aristotle will be launched at the very end of Q1 as we don't need the sales as covid testing is through the roof and they are currently extremely busy. Or as Covid testing slows down Cancer testing begins. No need to do both tests at the same time, spread the sales out to show steady growth.
3. Aristotle will be launched at the very end of Q1 so they don't need to report any sales or no sales of Aristotle for 5-6 more months when Q2 is reported.
4. Aristotle isn't launched in Q1
as investors we need to ask ourselves are you buying or selling because my thesis is........